Haas Jason 4

What Happened
Jason Haas, Chief Financial Officer of Odyssey Therapeutics (ODTX), purchased 1,000 shares on May 8, 2026 at $20.00 per share for a total transaction value of $20,000. The transaction is reported as a purchase (Form 4 code P), described as an open-market or private purchase.

Key Details

• Transaction date: 2026-05-08
• Filing date (Form 4): 2026-05-11 (timely)
• Shares purchased: 1,000
• Price per share: $20.00
• Total value: $20,000
• Transaction type: Purchase (open-market/private purchase), Form 4 code P
• Shares owned after transaction: Not specified in the supplied filing excerpt
• No footnotes or 10b5-1 plan details provided in the supplied data

Context
Insider purchases (especially by senior officers) are often viewed by investors as a generally positive sign, though a single small purchase — $20k in this case — is modest and not definitive on its own. For full ownership figures and any additional notes, consult the complete Form 4 on SEC EDGAR.